Inactivated and subunit vaccines to prevent shigellosis

Expert Review of Vaccines
Robert W Kaminski, Edwin V Oaks

Abstract

Shigellosis remains a formidable disease globally, with children of the developing world bearing the greatest number of infections. The need for an affordable, safe and efficacious vaccine has persisted for decades. Vaccines to prevent shigellosis can be divided into living and nonliving approaches. Several nonliving Shigella vaccines are currently at different stages of development and show substantial promise. Outlined here is an overview of multiple nonliving vaccine technologies, highlighting their current status and recent advances in testing. In addition, gaps in the knowledge base regarding immune mechanisms of protection are explored.

References

Sep 1, 1992·The American Journal of Tropical Medicine and Hygiene·C O TacketR Edelman
Jan 1, 1992·FEMS Microbiology Immunology·C SchultszI Ciznar
Jul 9, 1992·Nature·A ZychlinskyP J Sansonetti
Oct 1, 1991·Infection and Immunity·V I LevensonZ K Stassilevich
Nov 15, 1991·FEMS Microbiology Letters·A SenS Palchaudhuri
Nov 15, 1990·The New England Journal of Medicine·J B Robbins, R Schneerson
Jan 1, 1990·International Archives of Allergy and Applied Immunology·E V ChernokhvostovaV I Levenson
Jun 1, 1989·Infection and Immunity·T G ClearyJ J Calva
Jun 1, 1989·The Journal of Infectious Diseases·H L DuPontS B Formal
Sep 1, 1989·Molecular Microbiology·S M Payne
Jan 1, 1988·International Archives of Allergy and Applied Immunology·V I LevensonZ K Stasilevitch
Jan 1, 1967·Proceedings of the Society for Experimental Biology and Medicine·S B FormalS Berman
Feb 1, 1994·Molecular Microbiology·A ZychlinskyP J Sansonetti
Jul 1, 1996·Clinical and Diagnostic Laboratory Immunology·D CohenJ Shemer
Jul 1, 1996·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·D IslamA A Lindberg

❮ Previous
Next ❯

Citations

Jun 16, 2012·PloS One·Francesco Berlanda ScorzaChristiane Gerke
Mar 13, 2014·Trends in Microbiology·Wilmara Salgado-PabónArmelle Phalipon
Aug 7, 2010·Current Opinion in Infectious Diseases·Margaret KosekMaribel Paredes Olortegui
Dec 14, 2011·Expert Review of Vaccines·Abbas MuhammadPavol Kudela
Dec 22, 2012·Expert Review of Vaccines·Ana Isabel CamachoCarlos Gamazo
Oct 11, 2012·Methods : a Companion to Methods in Enzymology·A I CamachoC Gamazo
Sep 17, 2013·Microbiology and Immunology·Soumik BarmanYoshifumi Takeda
Mar 17, 2016·Vaccine·Sachin ManiRichard I Walker
Jun 10, 2015·Immunology and Cell Biology·Malabi M Venkatesan
May 8, 2013·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Rezwanul WahidMarcelo B Sztein
Apr 22, 2015·Human Vaccines & Immunotherapeutics·Malabi M Venkatesan, Lillian L Van de Verg
Mar 12, 2013·International Journal of Medical Microbiology : IJMM·Madushini N DharmasenaDennis J Kopecko
May 20, 2014·Organic & Biomolecular Chemistry·Charles GauthierLaurence A Mulard
Apr 28, 2018·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Sihan WangZhenjia Wang
Nov 1, 2016·Clinical and Vaccine Immunology : CVI·Wilbur H Chen, Karen L Kotloff
Jan 10, 2014·Clinical and Vaccine Immunology : CVI·R W KaminskiE V Oaks
May 29, 2020·PLoS Neglected Tropical Diseases·Bakhos JneidStéphanie Simon
Jan 24, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·Shannon J HeineMarcela F Pasetti
Jul 18, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Cinzia ColomboLuigi Lay
Sep 16, 2020·Archives of Microbiology·Ahtesham Ahmad Shad, Wajahat Ahmed Shad
Jul 3, 2021·Microorganisms·Richard WalkerLouis Bourgeois

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.